§ 13F · FUND PROFILE
Fairmount Funds Management LLC.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · — (13F)Positions · 13Turnover · — · Q4Filed · Feb 17, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$1313.8T deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q4 2025
FILED FEB 17, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q4 |
|---|---|---|---|---|---|---|
| 1 | COGT | COGENT BIOSCIENCES INC | 9.00M | $319.8T | 24.3% | NEW |
| 2 | APGE | APOGEE THERAPEUTICS INC | 2.05M | $154.6T | 11.8% | NEW |
| 3 | SYRE | SPYRE THERAPEUTICS INC | 4.02M | $131.6T | 10.0% | NEW |
| 4 | VRDN | VIRIDIAN THERAPEUTICS INC | 3.91M | $121.8T | 9.3% | NEW |
| 5 | ORKA | ORUKA THERAPEUTICS INC | 3.71M | $112.3T | 8.5% | NEW |
| 6 | DNTH | DIANTHUS THERAPEUTICS INC | 2.14M | $88.1T | 6.7% | NEW |
| 7 | ZBIO | ZENAS BIOPHARMA INC | 2.21M | $80.2T | 6.1% | NEW |
| 8 | NUVL | NUVALENT INC | 728K | $73.2T | 5.6% | NEW |
| 9 | JBIO | JADE BIOSCIENCES INC | 4.55M | $70.3T | 5.3% | NEW |
| 10 | ELVN | ENLIVEN THERAPEUTICS INC | 3.71M | $57.2T | 4.4% | NEW |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE FAIRMOUNT SIGNAL
AC read
Fairmount Funds Management LLC is classified as a Other fund.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
1 FILINGS
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed
Q1 2025
Steady book
+0 buys · −0 exits · 0 changed